ImmunoGen
IMGN
#1843
Rank
NZ$15.45 B
Marketcap
$55.33
Share price
0.00%
Change (1 day)
161.10%
Change (1 year)

Operating Margin for ImmunoGen (IMGN)

Operating Margin as of December 2024 (TTM): -203.81%

According to ImmunoGen 's latest financial reports and stock price the company's current Operating Margin is -203.81%. At the end of 2022 the company had an Operating Margin of -203.81%.

Operating Margin history for ImmunoGen from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2022-203.81%2.21%
2021-199.41%494.57%
2020-33.54%-73.5%
2019-126.57%-59.42%
2018-311.94%275.08%
2017-83.17%-65.26%
2016-239.42%237.18%
2015-71.01%-40.4%
2014-119.15%-41.85%
2013-204.90%-54.29%
2012-448.24%48.49%
2011-301.86%-17.76%
2010-367.04%220.66%
2009-114.47%44.01%
2008-79.49%60.26%
2007-49.60%-10.67%
2006-55.53%81.58%
2005-30.58%35.17%
2004-22.62%-91.35%
2003-261.49%6.08%
2002-246.51%16.56%
2001-211.49%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-30.69%-84.94%๐Ÿ‡บ๐Ÿ‡ธ USA
14.38%-107.06%๐Ÿ‡บ๐Ÿ‡ธ USA
24.84%-112.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-14.50%-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA
17.68%-108.67%๐Ÿ‡บ๐Ÿ‡ธ USA
1.80%-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
25.49%-112.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
15.40%-107.56%๐Ÿ‡ซ๐Ÿ‡ท France

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.